Health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in treatment-naÏve adults with Genotype 1B (GT1B) Chronic Hepatitis C
Abstract
Authors
Y. Liu D. Bernstein L. Larsen D. Cohen Y. Xie T. Juday